Pilot study evaluating feasibility and benefits of telemonitored NIV (noninvasive ventilation) treatment on COPD (chronic obstructive pulmonary disease) patients.

Multicentric Randomized Controlled Trial

Primary Objective:

To evaluate benefits of telemonitoring system, Easy Care Online (ECO), on NIV long term treatment efficacy and patient compliance

Secondary Objectives:

To determine predictive factors of COPD exacerbation in patients treated by NIV with ECO To carry out a health economic evaluation on telemonitoring benefits in COPD pts treated with NIV

Inclusion Criteria:

• COPD patient already treated by NIV requiring therapy assessment in their routine care Follow-Up or
• COPD patient requiring de Novo NIV therapy according to routine care rules (NIV<12h)
• Patient requiring NIV therapy by S9 VPAP ST +/- oxygen therapy
• Patient willing to participate to the study
• Patient or attendant able to complete patient passport and to come to Follow-Up visits.

Exclusion Criteria:

• NIV therapy Failure during screening phase (intolerance, patient refusal, significant leaks, significant AHI or Oxymetry events)
• Hospitalization conducting to NIV discontinuation for at least 1 week during the screening phase